The early morning buzz had all the flavor of moldy cheese. Europe blowing up, Japan ailing and the U.S. stock market futures diving had everyone reaching for the panic button.
But it hasn't unfolded according to script. At midmorning, the major measures are certainly down, but not down in the way the early indicators had threatened. Instead of plunging to another eye-popping loss, it seems that things have already started to stabilize. Things remain fragile, but the anticipated blood bath has yet to unfold.
Why? According to trading desks, a big hedge fund is moving or has moved a big basket of European stocks -- billions. In order to move that kind of product, institutions bid prices lower to find buyers and increase liquidity. This one-time event would explain why the markets whooshed lower and then started bouncing higher.
If that is what's going on -- and it's not something darker and more fundamental like a collapsing European or Japanese bank -- we've seen it before. Almost a year ago, money-runner extraordinaire
George Soros decided to exit the market, and he took a lot of the
Nasdaq Composite and
Dow Jones with him. The Nasdaq dropped 9%, or 355 points. The Dow fell 616 points. And people screamed.
As market-watchers grasp at straws, trying to figure out what triggered this selloff -- the selloff could be over. That was one of the major frustrations with that April 14, 2000, plummet. A lot of money left on that day, and people couldn't figure out where the ruckus came from.
And what glitters best against a black velvet nightmare? Diamonds.
Here's an in-depth look at five stocks that might prove to be countertrend today. Some because of news, and many because brokerage firms are pushing them hard as go-to recommendations in the current confusion. A bewildered market can present opportunity.
Last night,
Kohl's (KSS Quote - Cramer on KSS - Stock Picks), the Midwestern department store chain, announced fourth-quarter earnings that were 48% higher than last year's numbers, surprising the professionals who watch this down-home discounter daily. Sales at stores open at least a year grew by a whopping 12.5%, topping the 11% estimate that had been expected. And when you factor in the 61 stores Kohl's has built all over the U.S. last year -- it made for a 38% ramp up in sales for the fourth quarter.
Simply put, the company came in with 52 cents a share this quarter, blasting last year's 36 cents and beating the 50 cent analyst estimate. Those are huge numbers from a brand that many investors know for its Nikes and Levis. The company also has given investors something to believe in, saying it will be going national over the next three to four years, opening 60 stores in 2001 and 70 stores in 2002 before moving into California and the Southwest in 2003.
In a retail environment that had a lousy Christmas and a lot of bad news from specialty retailers like the
Gap, Kohl's has dropped more than $10 from a 52-week high set a month ago. Welp, investors looking for a growth story certainly liked what they read about Kohl's. The stock is rallying this morning, thanks to a push from
Piper Jaffrey, the Minnesota-based brokerage firm that is nearby the Wisconsin-based company.
Investors turned to another familiar face,
Anheuser-Busch (BUD Quote - Cramer on BUD - Stock Picks), after August Busch III got a $3 million bonus for his great work in the past year. Beer sales, in total volume, are stronger than expected and the company, not far from 52-week highs, was up as well. Back in the beginning of February, Busch reported a 10% gain in fourth-quarter profits. In an environment filled with slowing earnings, the company also reaffirmed that earnings would grow by at least 12% in 2001, giving investors a feeling of calm lacking in the crazy world of technology. BUD is a bit higher this morning.
Not all technology names were kaput today.
SCI Systems (SCI Quote - Cramer on SCI - Stock Picks) was upgraded by
Thomas Weisel Partners, a brokerage firm, was up this morning after the company bought two manufacturing plants from
Nokia. The buy is quite the encouraging sign for the contract equipment manufacturer, which makes its money by making a wide array for technology for other companies. In a struggling environment where money is tight, these guys actually went out and bought something. That sent a positive sign to investors and analysts alike who were looking for things to buy today.
Mylan Laboratories (MYL Quote - Cramer on MYL - Stock Picks), a small generic drugmaker, was a winner, too. Last night, the David-sized company won a critical ruling against Goliath pharmaceutical
Bristol-Myers. Mylan can now go out and make a cheaper knockoff of BuSpar, Bristol-Myers' anti-anxiety drug. Judging from recent market activity, many investors are probably real familiar with anti-anxiety drugs. And with a ton of exclusive patents on major drugs about to expire in the next few years, this is quite a good sign for generic drugmakers as a whole. Mylan is off modestly this morning.
Last but not least,
Fannie Mae (FNM Quote - Cramer on FNM - Stock Picks) hit $74.70 as investors looked at last night's headlines. America's largest mortgage-finance company announced that 2001 would be good to it and actually raised its profit estimate for the year. The company said more and more people are refinancing because interest rates have dipped, a sign that the Fed's cut worked well for some people, at least. Earnings per share are now expected to grow by 14.9% from the previous estimate of 13.6%.
And
J.P. Morgan has upgraded the stock into the teeth of this storm. Another plus for investors looking for the countertrend.
Eric Gillin
RSS
